SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-10
DOI
10.1038/s41598-020-59057-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Actin Post-translational Modifications: The Cinderella of Cytoskeletal Control
- (2019) Sylvia Varland et al. TRENDS IN BIOCHEMICAL SCIENCES
- SETD3 is a positive regulator of DNA-damage-induced apoptosis
- (2019) Elina Abaev-Schneiderman et al. Cell Death & Disease
- Involvement of Actin Cytoskeletal Components in Breast Cancer Cell Fusion with Human Mesenchymal Stroma/Stem-Like Cells
- (2019) Catharina Melzer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural insights into SETD3-mediated histidine methylation on β-actin
- (2019) Qiong Guo et al. eLife
- SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients
- (2019) Hairu Yu et al. BMC CANCER
- A New Switch for TGFβ in Cancer
- (2019) Hsi-Wen Yeh et al. CANCER RESEARCH
- SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy
- (2019) Qingmei Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma
- (2019) Liangliang Xu et al. CLINICAL SCIENCE
- The Dual Role of Bone Morphogenetic Proteins in Cancer
- (2018) Duc-Hiep Bach et al. Molecular Therapy-Oncolytics
- Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis
- (2018) Marilena Tauro et al. Cancers
- Recent Advances in the Treatment of Breast Cancer
- (2018) Christy W. S. Tong et al. Frontiers in Oncology
- Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer–Mediated Cytotoxicity
- (2018) Antoun Al Absi et al. CANCER RESEARCH
- Regulation of the master regulator FOXM1 in cancer
- (2018) Guo-Bin Liao et al. Cell Communication and Signaling
- The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion
- (2018) Marco Padilla-Rodriguez et al. Nature Communications
- SETD3 is an actin histidine methyltransferase that prevents primary dystocia
- (2018) Alex W. Wilkinson et al. NATURE
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- SETD3 protein is the actin-specific histidine N-methyltransferase
- (2018) Sebastian Kwiatkowski et al. eLife
- Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis
- (2017) Xiaoqing Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity
- (2017) Nicolas Skrypek et al. TRENDS IN GENETICS
- Actin stress fiber organization promotes cell stiffening and proliferation of pre-invasive breast cancer cells
- (2017) Sandra Tavares et al. Nature Communications
- Strong fascin expression promotes metastasis independent of its F-actin bundling activity
- (2017) Lisa S. Heinz et al. Oncotarget
- Chromatin associated SETD3 negatively regulates VEGF expression
- (2016) Ofir Cohn et al. Scientific Reports
- Clinical management of breast cancer heterogeneity
- (2015) Dimitrios Zardavas et al. Nature Reviews Clinical Oncology
- Differential nuclear shape dynamics of invasive andnon-invasive breast cancer cells are associated with actin cytoskeleton organization and stability
- (2014) Rena Chiotaki et al. Biochemistry and Cell Biology
- Movers and shakers: cell cytoskeleton in cancer metastasis
- (2014) C M Fife et al. BRITISH JOURNAL OF PHARMACOLOGY
- Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis
- (2013) Vanessa Y Tan et al. BMC Medicine
- The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis
- (2013) Z. Chen et al. HAEMATOLOGICA
- α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma
- (2013) Lei Ding et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer
- (2013) Wen-Quan Wang et al. PLoS One
- Novel functions of FoxM1: from molecular mechanisms to cancer therapy
- (2013) Mónica Alvarez-Fernández et al. Frontiers in Oncology
- Post-translational modification and regulation of actin
- (2012) Jonathan R Terman et al. CURRENT OPINION IN CELL BIOLOGY
- Histone methylation: a dynamic mark in health, disease and inheritance
- (2012) Eric L. Greer et al. NATURE REVIEWS GENETICS
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- FoxM1 Regulates Mammary Luminal Cell Fate
- (2012) Janai R. Carr et al. Cell Reports
- Targeting tumor cell motility to prevent metastasis
- (2011) Trenis D. Palmer et al. ADVANCED DRUG DELIVERY REVIEWS
- Jetset: selecting the optimal microarray probe set to represent a gene
- (2011) Qiyuan Li et al. BMC BIOINFORMATICS
- RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data
- (2011) Balázs Győrffy et al. BREAST CANCER RESEARCH AND TREATMENT
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules
- (2011) Monther Al-Alwan et al. PLoS One
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
- (2010) Chrisostomi Gialeli et al. FEBS Journal
- Uncovering the Human Methyltransferasome
- (2010) Tanya C. Petrossian et al. MOLECULAR & CELLULAR PROTEOMICS
- miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness
- (2010) M Götte et al. ONCOGENE
- FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance
- (2010) J Millour et al. ONCOGENE
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- EMT, the cytoskeleton, and cancer cell invasion
- (2009) Mahmut Yilmaz et al. CANCER AND METASTASIS REVIEWS
- Cell biology of the movement of breast cancer cells: Intracellular signalling and the actin cytoskeleton
- (2009) Ping Jiang et al. CANCER LETTERS
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Bone Morphogenetic Protein-10 Suppresses the Growth and Aggressiveness of Prostate Cancer Cells Through a Smad Independent Pathway
- (2009) Lin Ye et al. JOURNAL OF UROLOGY
- Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
- (2009) Axel Grothey et al. Nature Reviews Clinical Oncology
- Histone methyltransferases in cancer
- (2009) Mareike Albert et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
- (2008) D. Barkan et al. CANCER RESEARCH
- Tumour maintenance is mediated by eNOS
- (2008) Kian-Huat Lim et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now